Get started
Author

Valeria Calafiore

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia
2019 · Adriano Venditti, Alfonso Piciocchi, et al. · Blood · 227
PDF
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia
2018 · Anna Lucia Fedullo, Monica Messina, et al. · Haematologica · 88
PDF
Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes
2019 · Stefania Bramanti, Valeria Calafiore, et al. · Transplantation and Cellular Therapy · 69
PDF
Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review
2023 · Gaetano Giuffrida, Uros Markovic, et al. · Orphanet Journal of Rare Diseases · 62
PDF
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents
2017 · Alessandra Romano, Nunziatina Laura Parrinello, et al. · Blood Cancer Journal · 44
PDF
Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits
2019 · Mario Schiavoni, Mariasanta Napolitano, et al. · Frontiers in Medicine · 36
PDF
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network
2019 · Concetta Conticello, Alessandra Romano, et al. · Journal of Clinical Medicine · 28
PDF
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph’+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
2018 · Maria Cristina Pirosa, Salvatore Leotta, et al. · Chemotherapy · 24
Prognostic Assessment and Treatment of Primary Gastric Lymphomas: How Endoscopic Ultrasonography Can Help in Tailoring Patient Management
2013 · Calogero Vetro, Annalisa Chiarenza, et al. · Clinical Lymphoma Myeloma & Leukemia · 21
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial
2024 · Adriano Venditti, Alfonso Piciocchi, et al. · Blood Advances · 14
PDF
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
2019 · Marina Silvia Parisi, Salvatore Leotta, et al. · Journal of Clinical Medicine · 14
PDF
Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response
2018 · Roberto Mina, Maria Teresa Petrucci, et al. · Clinical Lymphoma Myeloma & Leukemia · 14
PDF
Real‐World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi‐Resistant Chronic‐Phase Chronic Myeloid Leukemia (CML‐CP) Patient Population
2025 · Massimo Breccia, Antonella Russo Rossi, et al. · Hematological Oncology · 13
PDF
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol
2021 · Francesco Buccisano, Raffaele Palmieri, et al. · Blood Advances · 11
PDF
A Real-Life Survey of Venous Thromboembolic Events Occurring in Myeloma Patients Treated in Third Line with Second-Generation Novel Agents
2020 · Valeria Calafiore, Silvia Giamporcaro, et al. · Journal of Clinical Medicine · 8
PDF
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance
2023 · Gaetano Giuffrida, Uros Markovic, et al. · European Journal Of Haematology · 7
PDF
Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia
2024 · Roberto Bono, Giuseppe Sapienza, et al. · Cells · 6
PDF
Effectiveness and Safety of Eliglustat Treatment in Gaucher Disease: Real-life Unicentric Experience
2023 · Andrea Duminuco, Manlio Fazio, et al. · Clinical Therapeutics · 6
PDF
P686: Real-world Efficacy Profile of Asciminib in an Italian, Multi-resistant Chronic-phase Chronic Myeloid Leukemia (cp-cml) Patient Population
2023 · Massimo Breccia, Antonella Russo Rossi, et al. · HemaSphere · 6
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy
2022 · Monica Bocchia, Angelo Michele Carella, et al. · Pharmacogenomics and Personalized Medicine · 6
PDF
Pomalidomide Experience: An Effective Therapeutic Approach with Immunomodulatory Drugs in A Patient with Relapsed-Refractory Multiple Myeloma
2017 · Concetta Conticello, Marina Parisi, et al. · Future Oncology · 5
Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis
2024 · Giuseppe Sapienza, Marta Castronovo, et al. · Frontiers in Oncology · 4
PDF
Extramedullary Acute Myeloid Leukemia: Evaluating Azacitidine—Venetoclax Combination Outcomes and the Role of Molecular Genetics and Bone Marrow Involvement
2025 · Fanny E. Palumbo, Calogero Vetro, et al. · European Journal Of Haematology · 3
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study
2024 · Salvatore Leotta, Uros Markovic, et al. · Annals of Hematology · 3
PDF
Results of the 6-Year Follow-up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia
2021 · Adriano Venditti, Alfonso Piciocchi, et al. · Blood · 3
Works count: 54
Citation count: 744
H-index: 13
I10-index: 14
Year
Topic
Type